Endometrioid ovarian cysts: A rationale for post-operative hormonal therapy
Давыдов А. И., Белоцерковцева Л. Д., Таирова М. Б.
Вопросы гинекологии, акушерства и перинатологии
Т. 18, Вып. 2, С. 122-128
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.20953/1726-1678-2019-2-122-128
Аннотация:
The role of endogenous and exogenous estradiol (EE) in the morphogenesis and therapy of endometriosis has been discussed in literature over the past years. As has been found, the endometrioid tissue itself produces estradiol from inactive precursors, synthesised in the adrenal glands. Hence EE cannon influence the growth of endometriosis in principle. On the contrary, EE enhances the inhibitory effect of progestogens (PG) on cellular growth of the ovarian endometrioma. This mechanism is based on induction of the progesterone receptor (PR) expression with subsequent enhancement of the PG effect. Simultaneous introduction of EE and PG promotes rapid PR induction, ensuring the maximal antiproliferative effect of PG. This can basically change the understanding of hormone therapy in patients with endometriosis, giving preference to combined hormonal contraceptives containing PG with the maximal antiproliferative activity – dienogest. © 2019, Dynasty Publishing House. All rights reserved.
Ключевые слова:
Combined hormonal contraception; Dienogest; Endometrioid ovarian cyst; Endometriosis; Ethinylestradiol
contraceptive agent; dienogest; estradiol; progesterone receptor; antiproliferative activity; Article; cell growth; endometrioid ovarian cyst; endometriosis; endometrium tumor; hormonal therapy; human; ovary cyst; postoperative care
Язык текста: Русский
ISSN: 2414-9152
Давыдов А. И. Александр Ильгизирович 1961-
Белоцерковцева Л. Д.
Таирова М. Б. Марина Борисовна 1985-
Davy'dov A. I. Aleksandr Il`gizirovich 1961-
Belotserkovtseva L. D.
Tairova M. B. Marina Borisovna 1985-
Endometrioid ovarian cysts: A rationale for post-operative hormonal therapy
Текст визуальный непосредственный
Вопросы гинекологии, акушерства и перинатологии
ООО "Издательство "Династия"
Т. 18, Вып. 2 С. 122-128
2019
Статья
Combined hormonal contraception Dienogest Endometrioid ovarian cyst Endometriosis Ethinylestradiol
contraceptive agent dienogest estradiol progesterone receptor antiproliferative activity Article cell growth endometrioid ovarian cyst endometriosis endometrium tumor hormonal therapy human ovary cyst postoperative care
The role of endogenous and exogenous estradiol (EE) in the morphogenesis and therapy of endometriosis has been discussed in literature over the past years. As has been found, the endometrioid tissue itself produces estradiol from inactive precursors, synthesised in the adrenal glands. Hence EE cannon influence the growth of endometriosis in principle. On the contrary, EE enhances the inhibitory effect of progestogens (PG) on cellular growth of the ovarian endometrioma. This mechanism is based on induction of the progesterone receptor (PR) expression with subsequent enhancement of the PG effect. Simultaneous introduction of EE and PG promotes rapid PR induction, ensuring the maximal antiproliferative effect of PG. This can basically change the understanding of hormone therapy in patients with endometriosis, giving preference to combined hormonal contraceptives containing PG with the maximal antiproliferative activity – dienogest. © 2019, Dynasty Publishing House. All rights reserved.